1. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 2007; 156: 428–32.
2. Zouboulis CC. Sebaceous gland receptors. Dermatoendocrinol 2009; 1 (2):77–80. PubMed PMID: 20224688; PubMed Central PMCID: PMC2835895.
3. Nagy I, Pivarcsi A, Kis K et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006: 8: 2195–205.
4. Kim J, Ochoa MT, Krutzik SR et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002: 169: 1535–41.
5. Berbis P. [Retinoids: mechanisms of action] Ann Dermatol Venereol 2010;137 (Suppl. 3): S97–103. French.
6. Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol 2005; 4 (1): 41–7.
7. Valins W, Amini S, Berman B. The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators. J Clin Aesthet Dermatol 2010; 3 (9): 20–9.
8. Dréno B, Kaufmann R, Talarico S et al Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study. Br J Dermatol 2011. doi: 10.1111/j.1365–2133.2011.10374.x.
9. Webster GF. Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne. J Drugs Dermatol 2011; 10 (6): 636–44.
10. Leyden JJ, Preston N, Osborn C et al. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol 2011; 4 (5): 22–6.
11. Feldman SR, Tan J, Poulin Y et al. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. J Am Acad Dermatol 2011; 64 (6): 1085–9.
12. Kubota Y, Munehiro A, Shirahige Y et al. Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris. J Dermatolog Treat 2011. [Epub ahead of print] PubMed PMID: 21254867.
13. Munehiro A, Murakami Y, Shirahige Y et al. Combination effects of cosmetic moisturisers in the topical treatment of acne vulgaris. J Dermatolog Treat 2011. [Epub ahead of print] PubMed PMID: 21756149.
14. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol 2011; 4 (2): 40–7.
15. Song M, Seo SH, Ko HC et al. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea. J Dermatol 2010. doi: 10.1111/j.1346-8138.2010.01109.x.
16. Draelos ZD, Potts A, Alió Saenz AB; W0265-306 Study Group. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris. Cutis 2010; 86 (6): 310–8.
17. Webster G, Thiboutot DM, Chen DM et al. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris. Cutis 2010; 86 (5): 263–7.
18. Tunca M, Akar A, Ozmen I et al. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne. Int J Dermatol 2010; 49 (12): 1440-4. doi: 10.1111/j.1365-4632.2010.04601.x.
19. Масюкова С.А., Гладько В.В., Бекмагомаева З.А. Опыт применения нового топического ретиноида – адапалена в лечении акнэ. Клинич. дерматол. и венерол. 2002; 2: 36–9.
20. Монахов С.А. «Shift”, или Комбинированно-последовательная терапия акне. Совр. проблемы дерматовенерол., иммунол. и врачебной косметол. 2010, 5 (12): 53–9.

Е.В.Свирщевская1, Е.В.Матушевская2
1. Институт биоорганической химии РАН;
2. ГОУ ДПО ИПК ФМБА России, Москва